Skip to main content
. 2021 Mar 10;13(3):888. doi: 10.3390/nu13030888

Figure 1.

Figure 1

The effect of MTX and increasing concentrations of n-3 PUFAs on HT 29 and HCT 116 cell viability. PrestoBlue® assay was used to evaluate cell viability. MTX-methotrexate, n-3 polyunsaturated fatty acids. Values are mean ± SEM. * p < 0.05 MTX-treated vs. MTX-non-treated cells, p < 0.05 viability late vs. initial.